These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25133432)

  • 1. Histologic features mimicking mycosis fungoides induced by imiquimod, 5%: a potential pitfall for dermatopathologists.
    Altamura D; Simonacci F; Hirbod T; Arkoumani E; Verdolini R
    JAMA Dermatol; 2014 Nov; 150(11):1236-7. PubMed ID: 25133432
    [No Abstract]   [Full Text] [Related]  

  • 2. Lupus erythematosus-like imiquimod reaction: a diagnostic pitfall.
    Barr KL; Konia TH; Fung MA
    J Cutan Pathol; 2011 Apr; 38(4):346-50. PubMed ID: 20726930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe systemic reaction to topical imiquimod.
    Heikkinen AK; Susitaival P
    Acta Derm Venereol; 2011 Sep; 91(5):594-5. PubMed ID: 21629973
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of recalcitrant skin ulcers as a side-effect of treatment with topical 5% imiquimod cream: report of two cases.
    Kalampalikis A; Goetze S; Elsner P
    J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1574-6. PubMed ID: 24456017
    [No Abstract]   [Full Text] [Related]  

  • 5. Imiquimod 5% cream induced psoriasis: a case report, summary of the literature and mechanism.
    Patel U; Mark NM; Machler BC; Levine VJ
    Br J Dermatol; 2011 Mar; 164(3):670-2. PubMed ID: 21062268
    [No Abstract]   [Full Text] [Related]  

  • 6. [Erythema multiforme due to 5% imiquimod cream].
    García-Arpa M; Rodríguez-Vázquez M; Delgado Portela M; Vera Iglesias E
    Actas Dermosifiliogr; 2010 Jul; 101(6):551-2. PubMed ID: 20738976
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe reaction to 5% imiquimod cream with excellent clinical and cosmetic outcomes.
    Greenberg HL; Cohen JL; Rosen T; Orengo I
    J Drugs Dermatol; 2007 Apr; 6(4):452-8. PubMed ID: 17668546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythema multiforme induced by imiquimod 5% cream.
    Ballester I; Guijarro J; Silvestre JF; Niveiro M
    Int J Dermatol; 2014 Jul; 53(7):e347-8. PubMed ID: 24602041
    [No Abstract]   [Full Text] [Related]  

  • 9. Morbilliform exanthem induced by imiquimod in a patient with drug-related immunosuppression.
    Cavicchini S; Vezzoli P; Muratori S; Gianotti R
    Clin Exp Dermatol; 2009 Jun; 34(4):526-7. PubMed ID: 19196306
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of imiquimod-induced alopecia.
    Conde J; Davis K; Ntuen E; Balmer N; Jones D; McMichael A
    J Dermatolog Treat; 2010 Mar; 21(2):122-4. PubMed ID: 19488918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imiquimod induces complete clearance of a PUVA-resistant plaque in mycosis fungoides.
    Dummer R; Urosevic M; Kempf W; Kazakov D; Burg G
    Dermatology; 2003; 207(1):116-8. PubMed ID: 12835571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of subacute cutaneous lupus erythematosus associated with the use of imiquimod to treat actinic keratoses.
    Burnett TJ; English JC; Ferris LK
    J Drugs Dermatol; 2010 Aug; 9(8):1022-4. PubMed ID: 20684157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical Imiquimod in the Treatment of Conjunctival Actinic Keratosis.
    Rowlands MA; Giacometti JN; Servat J; Materin MA; Levin F
    Ophthalmic Plast Reconstr Surg; 2017; 33(1):e21-e23. PubMed ID: 25853505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imiquimod 3.75% cream (Zyclara) for the treatment of actinic keratoses.
    Quist SR; Gollnick HP
    Expert Opin Pharmacother; 2011 Feb; 12(3):451-61. PubMed ID: 21254950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycosis fungoides manifesting as a morbilliform eruption mimicking a viral exanthem.
    Jenkinson HA; Aung PP; Huen A
    Cutis; 2020 Jun; 105(6):E27-E29. PubMed ID: 32717002
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of dosing frequency on the safety and efficacy of imiquimod 5% cream for treatment of actinic keratosis on the forearms and hands: a phase II, randomized placebo-controlled trial.
    Gebauer K; Shumack S; Cowen PS
    Br J Dermatol; 2009 Oct; 161(4):897-903. PubMed ID: 19545297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the back of the hands to apply imiquimod.
    Hogan K; Cullan J; Isedeh P; Aires D
    J Am Acad Dermatol; 2016 Jan; 74(1):e17. PubMed ID: 26702809
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical experience of imiquimod 3.75% for actinic keratosis: results from a case series.
    Tambone S; Fargnoli MC; Capizzi R; Peris K
    G Ital Dermatol Venereol; 2018 Jun; 153(3):333-337. PubMed ID: 26439591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recruitment of plasmacytoid dendritic cells to skin regulates treatment responsiveness of actinic keratosis to imiquimod.
    Ogawa Y; Kawamura T; Matsuzawa T; Aoki R; Shimada S
    J Dermatol Sci; 2014 Oct; 76(1):67-9. PubMed ID: 25088809
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of patch and plaque stage mycosis fungoides with imiquimod 5% cream.
    Deeths MJ; Chapman JT; Dellavalle RP; Zeng C; Aeling JL
    J Am Acad Dermatol; 2005 Feb; 52(2):275-80. PubMed ID: 15692473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.